FOX Translator
No data currently available.
No data currently available.
In the wide and varied family of the thousands and thousands of funds out there, the exchange-traded fund is one of the more consumer-friendly ones.
Unlike mutual funds, exchange-traded funds, or ETFs, behave more like stocks. You can buy
into an ETF at any time, and sell it whenever you feel like it. And like a stock, an ETF's value can rise and fall--depending
on what the ETF is invested in.What do ETFs invest in? Well, they're typically linked to an index like the Dow Jones Industrial
Average or the S&P 500. So, if you had an ETF that trades the same companies that make up the Dow or the S&P, it will
rise and fall in value pretty much the same amount as the Dow or S&P.
You can also buy ETFs that invest in other
types of products, like bonds, currencies, gold or other commodities. The ETF market has grown considerably in the past few
years, so there is no shortage of ETFs to invest in.
Home / Markets / Industries / Health Care
Wednesday, May 21, 2008
Linkwell Corporation Announces Receipt of Business Plan from Wharton-Fudan Universities
Comtex
SHANGHAI, China, May 21, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX/ ----Linkwell Corporation (Linkwell or the Company) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced today they were in receipt of a detailed comprehensive business plan from Wharton and Fudan Universities as a result of the Wharton Global Consulting Practicum (GCP) program. The program concluded with a two day colloquium on May 13th and 14th at Wharton College and the University of Pennsylvania in Philadelphia.
"We are very appreciative of everyone involved in the GCP program," commented Linkwell Chairman and CEO, Mr. Xuelian Bian. "The process and products will help us to reach the next two levels in our business development." The program's objectives were to bring new strategic thinking and ideas to Linkwell; discuss growth plan details, action steps, and share critical factors for driving growth; discuss the business plan; engage industry experts on relevant topics for insights; and provide written materials to the Company, including a business plan, to accomplish these objectives.
During the GCP program which lasted six months, participants evaluated 5 disinfectant markets for size, growth trends, risks and barriers to entry. Then they developed a deep analysis of the market environment for the medical sector, with special focus on customers; competitors; distribution network analysis; and growth strategy initiatives. The program concluded with the writing and presentation of a customized business plan containing financial projections; a funding plan; an implementation plan for growth initiatives, including sales effectiveness, pricing, marketing, innovations, acquisitions and pharmacy market sizing.
The GCP report stated, "Already exceeding RMB 6.5B (US$ 928M), China's medical disinfectant market is expected to grow steadily at 15% over the next five years. Beyond medical disinfectants, opportunities abound in China's nascent home-use disinfectants market (approximately RMB 14B/US$ 2B and growing at 13% per year) and the market for commercial-use disinfectants (approximately RMB 4B/US$ 571M and growing at 15% per year)". GCP recommended Linkwell Corporation focus on medical disinfectants at the present time, then go into home-use disinfectants market in the near future.
"The preparation and research was detailed, academically rigorous, practical," commented Linkwell COO, Mr. Arthur Huang. "The planning is pragmatic, creative, innovative, flexible; I believe we can integrate their four stage business strategy with the one we had created."
The plan and other products provide Linkwell with deep market analysis, including opportunities and risks and a thorough corporate analysis of Linkwell and the competition's strengths and weaknesses. In the colloquium, Linkwell's management team dialogued with many industry experts, including sales, marketing and law experts. Many of these experts serve on the GCP board of directors with many years of experience in their fields, and shared their real-life advice and experience to Linkwell.
Mr. Bian concluded, "We highly value the Wharton GCP four stage business strategy and support products. Everyone has lived up to Wharton and Fudan's esteemed reputation and their work was truly impressive and greatly appreciated. In fact, we believe that this information is so powerful that we plan to use it for years to come to help us grow into a large and successful company."
About Linkwell Corporation
Linkwell develops, manufactures and distributes disinfectant healthcare products in China through its subsidiary LiKang Disinfectant. Linkwell's disinfectant healthcare products are a nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectants in liquid, tablet, powder and aerosol form. Through LiKang, Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China.
For more information, please visit http://www.linkwell.us .
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products; pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact: Investor Relations Craig Bird Segue Ventures LLC Tel: +1-215-885-4981 Email: chbird@segue.biz
SOURCE Linkwell Corporation
http://www.linkwell.us
Copyright (C) 2008 PR Newswire. All rights reserved
Market Snapshot
| Symbol | Last Price | Netchange | Volume |
|---|---|---|---|
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |






